The global inhalable biologics market is poised for extraordinary growth, as recent data reveals a compelling upward trend driven by increasing demand for non-invasive drug delivery systems, rapid technological advancements, and a surge in respiratory diseases worldwide. The market, valued at USD 3,210.0 million in 2023, is expected to rise to USD 3,710.4 million in 2024 and reach an impressive...
English
العربية
Français
Español
Português
Deutsch
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt